Who is eligible for clinical trial NCT05848570?

Participants must meet the protocol's inclusion criteria for HIV Infections. The stated age range is 13 Years to 34 Years. Confirm all requirements with the study coordinator.

Does clinical trial NCT05848570 provide travel or cost reimbursement?

Check with the site coordinator at the participating facility for travel and lodging stipend availability, and for which routine-care costs are covered.

🏛️ Verified NIH Record • Updated 2023-04-27

Keeping it LITE: Exploring HIV Risk in Vulnerable Youth With Limited Interaction and Digital Health Intervention (NCT05848570)

🟢 Recruiting Interventional Protocol 📊 Observational Clinical Research Sponsor: Hektoen Institute for Medical Research

🩺 Plain-English Summary (8th-Grade Level)

Despite advances in HIV diagnostics, care and prevention strategies, infection rates among adolescent and young adult sexual and gender minorities (SGM) continue to rise in the United States (US). There is an urgent need to describe the epidemiology and trajectories of HIV acquisition in this population and to offer age and culturally appropriate scalable prevention interventions to those at highest risk of infection in the US. This project will engage and retain young SGM in an innovative longitudinal cohort, enroll participants in a dynamic established digital health retention platform (HMP; HealthMPowerment), monitor HIV risk and prevention behaviors and explore the socioecological factors that influence the use of new HIV prevention technologies (UG3 phase), while also allowing targeted testing of novel digital health interventions (UH3 phase). In Aim 1, the investigators will enroll and retain a large (n=6000; 3000/year), diverse cohort of sexually active, SGM adolescents and young adults, ages 13-34, using innovative digital recruitment, engagement and retention strategies. Over the course of the study, the investigators will longitudinally characterize the sexual behavior, HIV transmission risk, and PrEP uptake trajectories of SGM youth utilizing epidemiological trajectory analyses to identify the most effective points of intervention (Aim 2). This study will capitalize upon productive existing partnerships and digital health expertise to articulate the drivers of the ongoing HIV epidemic among the most vulnerable populations in the US in order to identify the most effective, expeditious and scalable strategies to address this ongoing public health crisis.

Who can join: To join this study, participants generally need to meet the listed inclusion criteria (5 items) and avoid the listed exclusions (3 items).

Location: John H. Stroger, Jr. Hospital of Cook County — Chicago, Illinois

Age range: 13 Years to 34 Years

🧪 Interventions in This Study

Keeping it LITE (OTHER)

📋 "Do I Qualify?" — 1-Minute Self Screener

Instant Checklist

Check every box below. If you can check all of them, you may meet the study's basic screening requirements (final eligibility is confirmed by the site team).

For young adults ages 18-34: self-identified SGM young adults ages 18-34 who meet at least one of the following criteria:
1\) condomless anal or vaginal intercourse (CAI) with a cisgender man in the last 6 months OR
2\) sex with cisgender men and bacterial STI in the last 6 months OR
3\) anal or vaginal sex with a known HIV-infected partner in the last 6 months.
For adolescents 13-17: self-identified SGM adolescents ages 13-17 who have engaged in any sexual activity (e.g., oral, anal or vaginal sex)

Usually NOT eligible if any of the following apply:

Exclusion Criteria:
under age 13
over age 34

🔍 Extracted verbatim from the official NIH eligibility criteria. Always confirm with the study coordinator.

📍 All Participating Trial Locations (1 Sites)

John H. Stroger, Jr. Hospital of Cook County — Chicago, Illinois

📞 Contact the Study Coordinator

Phone: (312) 864-8030

Email: shosek@cookcountyhhs.org

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

💰 Cost, Insurance & Patient Rights

100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in HIV Infections

Testing a Real-time Electronic Antiretroviral Adherence Monitoring Intervention — Chicago, Illinois
The Ganchero Intervention for Migrant People Who Inject Drugs From Puerto Rico in New York City — New York, New York
An mHealth Intervention to Improve HIV Prevention Service Engagement Among People Who Use Drugs — La Jolla, California
A Setting Focus Overdose Prevention Intervention — Baltimore, Maryland
Implementation of an Opt-Out Testing and Rapid Diagnostic Strategy for Syphilis and HIV in Pregnant Patients Presenting to the Emergency Department — Houston, Texas

Explore by condition: All HIV Infections clinical trials

💡 How to Participate

Check the checklist above to see if you may qualify.
Contact the study coordinator using the phone/email above.
Ask about the visit schedule, what is covered at no cost, and any travel support.
Confirm with your own doctor before making a decision.

🏛️ View Official NIH Record ↗